Showing results (1121-1130 of 1,523) with videos related to
Sort By:
Pageof 153
Future Oncology (London, England)|November 9, 2020
The patient's perspective on treatment with dacomitinib: patient-reported outcomes from the Phase III trial ARCHER 1050Jean Paty, Rickard Sandin, Arlene Reisman, et al.Lung Cancer (Amsterdam, Netherlands)|November 29, 2020
Phase 1/2 study of ceritinib in Chinese patients with advanced anaplastic lymphoma kinase-rearranged non-small cell lung cancer previously treated with crizotinib: Results from ASCEND-6Yi-Long Wu, Yuankai Shi, Daniel Shao Weng Tan, et al.Lung Cancer (Amsterdam, Netherlands)|January 21, 2014
A multicenter phase II study of sorafenib monotherapy in clinically selected patients with advanced lung adenocarcinoma after failure of EGFR-TKI therapy (Chinese Thoracic Oncology Group, CTONG 0805)Qing Zhou, Cai-cun Zhou, Gong-yan Chen, et al.Translational Lung Cancer Research|May 20, 2021
Watershed analysis of the target pulmonary artery for real-time localization of non-palpable pulmonary nodulesXiang-Peng Chu, Zi-Hao Chen, Shao-Min Lin, et al.Annals of Surgical Oncology|December 5, 2012
KRAS mutation in patients with lung cancer: a predictor for poor prognosis but not for EGFR-TKIs or chemotherapyJi-lin Guan, Wen-zhao Zhong, She-juan An, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 3, 2023
Interface Engineering to Drive High-Performance MXene/PbS Quantum Dot NIR PhotodiodeYunxiang Di, Kun Ba, Yan Chen, et al.BMJ Open|August 3, 2018
Insurance status and 1-year outcomes of stroke and transient ischaemic attack: a registry-based cohort study in ChinaHong-Qiu Gu, Zi-Xiao Li, Xing-Quan Zhao, et al.Biomarker Research|July 2, 2020
Clinical characteristics and prognostic value of the <i>KRAS G12C</i> mutation in Chinese non-small cell lung cancer patientsSi-Yang Liu, Hao Sun, Jia-Ying Zhou, et al.CNS Neuroscience & Therapeutics|June 23, 2015
Unfavorable Outcome of Thrombolysis in Chinese Patients with Cardioembolic Stroke: a Prospective Cohort StudyXin-Gao Wang, Li-Qun Zhang, Xiao-Ling Liao, et al.Annals of Translational Medicine|September 17, 2021
Guideline-directed low-density lipoprotein management in high-risk ischemic stroke or transient ischemic attack admissions in China from 2015 to 2019Hong-Qiu Gu, Kai-Xuan Yang, Xin Yang, et al.Pageof 153